| Literature DB >> 34884186 |
Joanna Dolar-Szczasny1, Jolanta Flieger2, Beata Kowalska3, Dariusz Majerek4, Małgorzata Tatarczak-Michalewska2, Izabela Zakrocka5, Wojciech Załuska5, Robert Rejdak1.
Abstract
Numerous reports have proven that dialysis patients experience disturbances in the levels of elements in biological fluids. Disturbances in the homeostasis of essential elements or the appearance of highly toxic elements are serious problems also in clinical ophthalmology. The purpose of this study was to investigate the influence of hemodialysis (HD) on the elemental composition of anterior chamber aqueous humor (AH) in patients undergoing cataract surgery. The study involved 22 patients. The control group enrolled 16 patients (age 75.68 ± 9.67, female 54.55%, male 45.45%) with cataract and normal kidney function (control), and the second group included six patients (age 70.33 ± 12.74, female 33.33%, male 66.67%) with cataract undergoing HD treatment. The elements quantification was established using an inductively coupled plasma optical emission spectrometer (ICP-MS). In the eye fluid of dialysis patients, there were increased levels of manganese (Mn) and mercury (Hg) and decreased levels of vanadium (V) and zinc (Zn). In addition, a statistically significant increase in the Hg/Zn and Hg/selenium (Se) ratios and a lowering of the iron (Fe)/Mn ratio were observed in the studied group in comparison to the control. The obtained results indicated the need for Zn and Se supplementation in order to eliminate the hazards caused by Hg toxicity. A lower level of V in the eye fluid of dialysis patients may have a positive effect on maintaining a calcium and phosphorus homeostasis. Our study gives a deep insight into changes of elements concentrations in AH induced by HD.Entities:
Keywords: ICP-MS; aqueous humor; cataract; hemodialysis; trace elements
Year: 2021 PMID: 34884186 PMCID: PMC8658160 DOI: 10.3390/jcm10235485
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Correlation matrices prepared for the controls (a) and cases (b).
Descriptive statistics of the studied groups of patients undergoing cataract surgery: the case group of HD patients undergoing hemodialysis (n = 6) and the control group of patients without hemodialysis (n = 16). Elemental mean concentrations expressed in µg L−1 are presented, together with spread measurements such as the variance coefficient (cv), standard deviation (sd), the first quartile (q1), and the third quartile (q3).
| Variable | Group | Min | Max | Median |
|
| Mean | sd | cv |
|---|---|---|---|---|---|---|---|---|---|
| Cs | control | 0.29 | 0.87 | 0.43 | 0.369 | 0.607 | 0.493 | 0.177 | 35.9 |
| case | 0.25 | 0.63 | 0.3 | 0.27 | 0.33 | 0.347 | 0.143 | 41.21 | |
| Eu | control | 0.07 | 0.29 | 0.125 | 0.108 | 0.23 | 0.158 | 0.07 | 44.3 |
| case | 0.08 | 0.21 | 0.1 | 0.09 | 0.11 | 0.115 | 0.048 | 41.74 | |
| Hf | control | 39.559 | 246.908 | 73.745 | 65.628 | 131.714 | 102.083 | 58.829 | 57.63 |
| case | 32.367 | 69.748 | 51.287 | 39.848 | 65.169 | 51.753 | 15.635 | 30.21 | |
| Nd | control | 0.41 | 1.958 | 0.795 | 0.651 | 1.314 | 1 | 0.468 | 46.8 |
| case | 0.5 | 1.207 | 0.562 | 0.501 | 0.62 | 0.658 | 0.275 | 41.79 | |
| Rb | control | 16.852 | 90.826 | 68.346 | 61.255 | 80.744 | 68.181 | 17.633 | 25.86 |
| case | 8.05 | 38.819 | 30.752 | 21.876 | 33.54 | 26.96 | 11.283 | 41.85 | |
| V | control | 3.093 | 9.873 | 4.906 | 4.022 | 6.636 | 5.55 | 2.161 | 38.94 |
| case | 0.93 | 5.822 | 2.093 | 1.209 | 2.81 | 2.483 | 1.814 | 73.06 | |
| Zn | control | 65.368 | 825.881 | 240.597 | 178.358 | 444.86 | 317.323 | 209.009 | 65.87 |
| case | 102.284 | 659.523 | 252.261 | 142.43 | 320.648 | 285.932 | 204.407 | 71.49 | |
| Mn | control | 8.88 | 341.835 | 21.919 | 13.149 | 39.837 | 46.73 | 80.514 | 172.3 |
| case | 13.282 | 142.479 | 75.839 | 39.219 | 114.46 | 76.964 | 51.141 | 66.45 | |
| Hg | control | 1.417 | 32.018 | 5.307 | 3.846 | 11.114 | 9.485 | 9.063 | 95.55 |
| case | 11.077 | 39.5 | 20.761 | 17.212 | 21.855 | 21.725 | 9.612 | 44.24 |
Results of statistically significant differences between the patient groups enrolled in the study (n = 22) in the nonparametric Mann–Whitney U test. Abbreviations: r—the rank-biserial correlation, CI—a confidence interval, and p—the probability value (p-value).
| Element |
| loge | r | CI95% |
|---|---|---|---|---|
| Cs | 0.030 | 4.36 | 0.62 | 0.18; 0.96 |
| Eu | 0.095 | 4.26 | 0.48 | 0.04; 0.94 |
| Hf | 0.025 | 4.37 | 0.65 | 0.30; 0.96 |
| Nd | 0.050 | 4.32 | 0.56 | 0.16; 0.94 |
| Rb | 0.002 | 4.51 | 0.90 | 0.62; 1.00 |
| V | 0.007 | 4.44 | 0.77 | 0.25; 1.00 |
| Zr | 0.043 | 4.33 | 0.58 | 0.20; 0.90 |
| Mn | 0.051 | 3.04 | −0.56 | −1.00; −0.16 |
| Hg | 0.011 | 2.56 | −0.73 | −0.92; −0.28 |
Figure 2Statistical significance of the differences of the metallic contents in AH of HD patients (cases) compared to the controls for Cs (ppb) (a), Hf (ppb) (b), Nd (ppb) (c), V (ppb) (d), Rb (ppb) (e), Zr (ppb) (f), Eu (ppb) (g), Hg (ppb) (h), Mn (ppb) (i).
Differences between the control (group I, n = 16) and HD patients (group 2, n = 6) considering the selected elemental ratios. Statistically significant correlations are marked in red.
| Element Ratios | Group 1 | Group 2 | n1 | n2 | Statistic |
|
|---|---|---|---|---|---|---|
| cadmium elimination | ||||||
| Cd/Ca | control | case | 16 | 6 | 37 | 0.449 |
| Cd/Cu | control | case | 16 | 6 | 44 | 0.802 |
| Cd/Fe | control | case | 16 | 6 | 45 | 0.858 |
| Cd/P | control | case | 16 | 6 | 41 | 0.641 |
| Cd/Se | control | case | 16 | 6 | 38 | 0.494 |
| Cd/Zn | control | case | 16 | 6 | 54 | 0.693 |
| iron balancing | ||||||
| Fe/Co | control | case | 16 | 6 | 39 | 0.541 |
| Fe/Cu | control | case | 16 | 6 | 50 | 0.914 |
| Fe/Mn | control | case | 16 | 6 | 82 | 0.010 |
| Fe/Ni | control | case | 16 | 6 | 36 | 0.407 |
| phosphorous balancing | ||||||
| P/Fe | control | case | 16 | 6 | 46 | 0.914 |
| P/Mg | control | case | 16 | 6 | 26 | 0.115 |
| P/V | control | case | 16 | 6 | 16 | 0.017 |
| P/Ca | control | case | 16 | 6 | 36 | 0.407 |
| sodium/potassium balancing | ||||||
| Na/K | control | case | 16 | 6 | 64 | 0.261 |
| mercury elimination | ||||||
| Hg/Se | control | case | 16 | 6 | 13 | 0.008 |
| Hg/Zn | control | case | 16 | 6 | 13 | 0.008 |
| lead, strontium elimination | ||||||
| Pb/Ca | control | case | 16 | 6 | 50 | 0.914 |
| Pb/Cu | control | case | 16 | 6 | 51 | 0.858 |
| Pb/Fe | control | case | 16 | 6 | 47 | 0.971 |
| Pb/Se | control | case | 16 | 6 | 45 | 0.858 |
| Pb/Zn | control | case | 16 | 6 | 49 | 0.971 |
| Sr/Ca | control | case | 16 | 6 | 31 | 0.231 |
Figure 3Differences in the Hg/Zn (a), Hg/Se (b), and P/V (c) ratios in AH of HD patients compared to the control.